Relay-Version: version B 2.10 5/3/83; site utzoo.UUCP Posting-Version: version B 2.10.2 9/5/84; site cadovax.UUCP Path: utzoo!watmath!clyde!burl!ulysses!allegra!mit-eddie!genrad!decvax!decwrl!pyramid!pesnta!hplabs!sdcrdcf!trwrb!trwrba!cadovax!keithd From: keithd@cadovax.UUCP (Keith Doyle) Newsgroups: net.sci,net.research,net.bio Subject: Copy protected Genes Message-ID: <970@cadovax.UUCP> Date: Wed, 27-Nov-85 17:14:36 EST Article-I.D.: cadovax.970 Posted: Wed Nov 27 17:14:36 1985 Date-Received: Tue, 10-Dec-85 05:08:35 EST Distribution: net Organization: CONTEL CADO Systems, Torrance, CA Lines: 34 Xref: watmath net.sci:490 net.research:374 net.bio:315 ......... There was a program on PBS a few weeks ago that talked about the preservation of variation in food-plant genes, that mentioned that companies like Monsanto are striving to 'copy protect' their new manufactured plant strains via gene-splicing in 'fingerprints' so that they can recoup the large expenditure required to develop such super-plants in the first place. I can see it now, farmers crops being checked for 'bootleg' plant strains, and involved in copyright infringement suits when caught. In addition, Monsanto is witholding what it learns about new bio-engineering techniques as proprietary. It seems that this proprietary business may be going a little too far. If companies strive to withold libraries of plant seeds etc., in order to protect their investments, we all suffer. It is likely too, that the majority of such discoveries may stay on laboratory shelves, when they cannot be directly tied to economically attractive products, or may compete with presently successful products already produced by the company. Once upon a time, the leading edge of technology tended to center around Universities that had no 'conflict of interest' in the dispersion of new technologies. Now however, the business community with it's larger R&D budget is changing all that, while at the same time causing the resultant products to cost more, and making it more difficult for smaller companies to compete. Keith Doyle # {ucbvax,ihnp4,decvax}!trwrb!cadovax!keithd # cadovax!keithd@ucla-locus.arpa